Shareholder Alert: Ademi LLP investigates whether Radius Health, Inc. has obtained a Fair Price in its transaction with Gurnet Point and Patient Square

MILWAUKEE, June 23, 2022 /PRNewswire/ -- Ademi LLP is investigating Radius (NASDAQ: RDUS) for possible breaches of fiduciary duty and other violations of law in its transaction with Gurnet Point and Patient Square. 

Click here to learn how to join the action: https://www.ademilaw.com/case/radius-health-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi LLP alleges Radius's financial outlook and prospects are excellent and yet Radius holders will receive only $10.00 per share in cash plus a Contingent Value Right (CVR) of $1.00 per share payable upon TYMLOS^® (abaloparatide) net sales reaching $300 million (inclusive of U.S. sales and Japan royalties or supply payments based on supply of TYMLOS for sale in Japan) during any consecutive 12-month period prior to December 31, 2025. The transaction values Radius at approximately $890 million, including the assumption of debt and assuming full payment of the CVR. The transaction agreement unreasonably limits competing bids for Radius by imposing a significant penalty if Radius accepts a superior bid. Radius insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Radius's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Radius.

If you own Radius common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/radius-health-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                          
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED